缩写名/全名 |
ANTI-CANCER AGENT ME
Anti-Cancer Agents in Medicinal Chemistry |
||||||||||||||||||||||||
ISSN号 | 1871-5206 | ||||||||||||||||||||||||
研究方向 | ONCOLOGY-CHEMISTRY, MEDICINAL | ||||||||||||||||||||||||
影响因子 | 2015:2.722, 2016:2.598, 2017:2.556, 2018:2.18, 2019:2.049, | ||||||||||||||||||||||||
出版国家 | U ARAB EMIRATES | ||||||||||||||||||||||||
出版周期 | Monthly | ||||||||||||||||||||||||
年文章数 | 197 | ||||||||||||||||||||||||
出版年份 | 2006 | ||||||||||||||||||||||||
是否OA | No | ||||||||||||||||||||||||
审稿周期(仅供参考) | 偏慢,4-8周 |
||||||||||||||||||||||||
录用比例 | 较易 | ||||||||||||||||||||||||
投稿链接 | http://benthamscience.com/cmcaca/MSandI.htm | ||||||||||||||||||||||||
投稿官网 | http://benthamscience.com/cmcaca/ | ||||||||||||||||||||||||
h-index | 82 | ||||||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1871-5206%5BISSN%5D | ||||||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Nicotinamide Overcomes Doxorubicin Resistance of Breast Cancer Cells through Deregulating SIRT1/Akt Pathway. Author: Wei Y1, Guo Y1, Zhou J1, Dai K1, Xu Q1, Jin X2. Journal: Anticancer Agents Med Chem. 2019 Jan 14. doi: 10.2174/1871520619666190114160457. [Epub ahead of print] PubMed DOI |
2. | Synthesis of Oridonin Derivatives via Mizoroki-Heck Reaction and Click Chemistry for Cytotoxic Activity. Author: Hou W1, Fan Q2, Su L2, Xu H3. Journal: Anticancer Agents Med Chem. 2019 Jan 18. doi: 10.2174/1871520619666190118121439. [Epub ahead of print] PubMed DOI |
3. | Synthesis of Dual Target CPT-Ala-Nor Conjugates and Their Biological Activity Evaluation. Author: Zhao CK1, Xu L1, Wang XH1, Bao YJ1, Wang Y2. Journal: Anticancer Agents Med Chem. 2019 Jan 21. doi: 10.2174/1871520619666190121121933. [Epub ahead of print] PubMed DOI |
4. | Detection and Analysis of RNAs Expression Profile for Methylated Candidate Tumor Suppressor Genes in Nasopharyngeal Carcinoma. Author: Zhao S1, Zhang Y1, Liang X1, Li M1, Peng F1, Chen Z1, Chen Y1. Journal: Anticancer Agents Med Chem. 2019 Feb 3. doi: 10.2174/1871520619666190204094815. [Epub ahead of print] PubMed DOI |
5. | Analysis of Comparative Proteomic and Potent Targets of Peniciketal A in Human Acute Monocytic Leukemia. Author: Gao X1, Zhou Y2, Sun H1, Liu D1, Zhang J1, Zhang J1, Liu W1, Pan X1. Journal: Anticancer Agents Med Chem. 2019 Feb 12. doi: 10.2174/1871520619666190212124339. [Epub ahead of print] PubMed DOI |
6. | Cancer Therapy Based on Smart Drug Delivery with Advanced Nanoparticles. Author: Kong X1, Liu Y1, Huang X1, Huang S1, Gao F2, Rong P2, Zhang S2, Zhang K2, Zeng W1. Journal: Anticancer Agents Med Chem. 2019 Feb 12. doi: 10.2174/1871520619666190212124944. [Epub ahead of print] PubMed DOI |
7. | Astaxanthin Combine With Human Serum Albumin To Abrogate Cell Proliferation, Migration, And Drug-Resistant In Human Ovarian Carcinoma SKOV3 Cells. Author: Su XZ1, Chen R1, Wang CB1, Ouyang XL1, Jiang Y1, Zhu MY2. Journal: Anticancer Agents Med Chem. 2019 Feb 25. doi: 10.2174/1871520619666190225123003. [Epub ahead of print] PubMed DOI |
8. | Gossypetin Inhibits Solar-UV Induced Cutaneous Basal Cell Carcinoma Through Direct Inhibiting PBK/TOPK Protein Kinase. Author: Wang L1, Zhang Z1, Ge R1, Zhang J1, Liu W1, Mou K1, Lv S2, Mu X1. Journal: Anticancer Agents Med Chem. 2019 Mar 1. doi: 10.2174/1871520619666190301123131. [Epub ahead of print] PubMed DOI |
9. | Inhibition of Polo-Like Kinase 1 by BI2536 Reverses the Multidrug Resistance of Human Hepatoma Cells in Vitro and in Vivo. Author: Li H1, Luo F2, Li X3, Fu X1, He J1, Tian Y1, Zhu J1, Chu X1, Zhao H1. Journal: Anticancer Agents Med Chem. 2019 Mar 1. doi: 10.2174/1871520619666190301145637. [Epub ahead of print] PubMed DOI |
10. | Establishment and Characterization of Pemetrexed-Resistant NCI-H460/PMT Cells. Author: Xu YL1, Jiang XM1, Zhang LL1, Chen X1, Huang ZJ2, Lu JJ1. Journal: Anticancer Agents Med Chem. 2019 Mar 7. doi: 10.2174/1871520619666190307120441. [Epub ahead of print] PubMed DOI |
|
|